Glenn M. Chertow
Publication Details
-
Update on adverse drug events associated with parenteral iron.
Nephrol Dial Transplant. 2006; (2): 378-82
We previously compared the safety profile of three formulations of intravenous iron used during 1998-2000 and found higher rates of adverse drug events (ADEs) associated with the use of higher molecular weight iron dextran and sodium ferric gluconate complex compared with lower molecular weight iron dextran. Since that time, iron sucrose has become widely available and clinicians have gained additional experience with sodium ferric gluconate complex.
Help